MBX Biosciences Inc. Common Stock
MBX | NASDAQ
$62.13
+$1.19 (+1.95%)
Sep 22, 2026, 10:51 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 64K | 60K | 100K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 39K |
Gross Profit | n/a | -64K | -60K | -100K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -39K |
Operating Income | -40.93M | -27.27M | -25.8M | -23.93M | -21.81M | -26.53M | -18.61M | -19.61M | -16.66M | -13.31M | -9.99M | -10.95M | -8.01M |
Interest Income | 3.84M | 3.75M | -7.35M | 2.31M | 2.39M | 2.65M | 3.02M | 1.47M | 801K | 977K | 1.15M | 783K | 399K |
Pretax Income | -37.1M | -23.52M | -22.06M | -21.62M | -19.41M | -23.88M | -15.59M | -18.14M | -15.86M | -12.34M | -8.84M | -10.16M | -7.61M |
Net Income | -37.1M | -23.52M | -22.06M | -21.62M | -19.41M | -23.88M | -15.59M | -18.14M | -15.86M | -12.34M | -8.84M | -10.16M | -7.61M |
Selling & General & Admin | 9.95M | 8.79M | 6.04M | 4.66M | 4.08M | 4.12M | 3.39M | 2.87M | 2.26M | 2.27M | 2.26M | 1.87M | 1.49M |
Research & Development | 30.99M | 18.47M | 19.76M | 19.27M | 17.72M | 22.41M | 15.22M | 16.75M | 14.4M | 11.05M | 7.73M | 9.07M | 6.47M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 40.93M | 27.27M | 25.8M | 23.93M | 21.81M | 26.53M | 18.61M | 19.61M | 16.66M | 13.31M | 9.99M | 10.95M | 7.97M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 40.93M | 27.27M | 25.8M | 23.93M | 21.81M | 26.53M | 18.61M | 19.61M | 16.66M | 13.31M | 9.99M | 10.95M | 8.01M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 47.7M | 46.58M | 36.51M | 34.2M | 33.45M | 33.41M | 33.39M | 33.39M | 33.38M | 33.38M | 31.85M | 31.85M | 33.38M |
Shares Outstanding (Diluted) | 47.7M | 46.58M | 36.51M | 34.2M | 33.45M | 33.41M | 33.39M | 33.39M | 33.38M | 33.38M | 31.85M | 31.85M | 33.38M |
EPS (Basic) | -0.78 | -0.50 | -0.49 | -0.63 | -0.58 | -0.71 | -0.47 | -0.54 | -0.48 | -0.37 | -0.28 | -0.32 | -0.23 |
EPS (Diluted) | -0.78 | -0.50 | -0.49 | -0.63 | -0.58 | -0.71 | -0.47 | -0.54 | -0.48 | -0.37 | -0.28 | -0.32 | -0.23 |
EBITDA | -40.93M | -23.45M | -22M | -21.57M | -19.35M | -23.8M | -15.53M | -18.07M | -15.79M | -12.29M | -7.2M | -10.12M | -7.57M |
EBIT | n/a | -23.52M | -22.06M | -21.62M | -19.41M | -23.88M | -15.59M | -18.14M | -15.86M | -12.34M | -7.24M | -10.16M | -7.61M |
Depreciation & Amortization | n/a | 64K | 60K | 50K | 61K | 77K | 58K | 75K | 63K | 48K | 41K | 40K | 39K |
Add to Watchlist
Select watchlists to add or remove MBX